Evolus: Chiseling Away At The Aesthetic Market
May 25, 2024 at 18:20 PM EDT
Evolus is a facial beauty company that specializes in aesthetic neurotoxins. The market opportunity for Evolus is significant, with the neurotoxin market estimated at $3.5 billion and the dermal fillers market at $2.5 billion.
